Guggenheim analyst Jason Cassorla raised the firm’s price target on Universal Health (UHS) to $274 from $253 and keeps a Buy rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Raymond James Sees Market Cooling but These 2 Stocks Still Look Like Buys
- Universal Health price target raised to $259 from $249 at Wells Fargo
- Boeing upgraded, Charter downgraded: Wall Street’s top analyst calls
- Universal Health price target raised to $267 from $242 at Mizuho
- Universal Health upgraded to Outperform from Market Perform at Raymond James